Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Eurycomanone (Pasakbumin A) is cytotoxic on HepG2 cells by inducing apoptosis through the up-regulation of p53 and Bax, and down-regulation of Bcl-2.Eurycomanone has anti-cancer activity, inhibits A549 lung cancer cell proliferation in a dose-dependent manner at concentrations ranging from 5 to 20 μg/ml.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 41.00 | |
5 mg | In stock | $ 91.00 | |
10 mg | In stock | $ 148.00 | |
25 mg | In stock | $ 316.00 | |
50 mg | In stock | $ 475.00 | |
100 mg | In stock | $ 579.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 98.00 |
Description | Eurycomanone (Pasakbumin A) is cytotoxic on HepG2 cells by inducing apoptosis through the up-regulation of p53 and Bax, and down-regulation of Bcl-2.Eurycomanone has anti-cancer activity, inhibits A549 lung cancer cell proliferation in a dose-dependent manner at concentrations ranging from 5 to 20 μg/ml. |
Source |
Synonyms | Pasakbumin A |
Molecular Weight | 408.4 |
Formula | C20H24O9 |
CAS No. | 84633-29-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (122.43 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
EURYCOMANONE 84633-29-4 Others inhibit Pasakbumin A Phosphodiesterase (PDE) Inhibitor inhibitor